Hoth Therapeutics, Inc. Uncategorized Contracts & Agreements
20 Contracts & Agreements
- Renewal Agreement with Regus dated July 22, 2022 (Filed With SEC on March 31, 2023)
- Description of the Registrants Securities (Filed With SEC on March 31, 2023)
- Form of Placement Agent Warrants (Filed With SEC on December 30, 2022)
- Form of Pre-Funded Warrants (Filed With SEC on December 30, 2022)
- Description of the Registrants Securities (Filed With SEC on March 30, 2022)
- Description of the Registrants Securities (Filed With SEC on March 16, 2021)
- Form of Placement Agent Warrants (Filed With SEC on March 9, 2021)
- Form of Pre-Funded Warrants (Filed With SEC on March 9, 2021)
- Sponsored Research Agreement by and between the Company and the George Washington University (Filed With SEC on September 21, 2020)
- Novation Agreement by and among the Company, Chelexa BioSciences, Inc. and the University of Cincinnati dated May 14, 2020 (Filed With SEC on August 13, 2020)
- Royalty Agreement by and between the Company and Chelexa BioSciences, Inc. dated May 14, 2020 (Filed With SEC on August 13, 2020)
- Sublicense Agreement by and between the Company and Isoprene Pharmaceutics, Inc. dated July 30, 2020 (Filed With SEC on August 5, 2020)
- Sponsored Project Agreement by and between the Company and Virginia Commonwealth University (Filed With SEC on July 2, 2020)
- Renewal Agreement with Regus dated May 2, 2019 (Filed With SEC on March 2, 2020)
- Exclusive Sublicense Agreement between the Company and Zyl Therapeutics, Inc (Filed With SEC on August 23, 2019)
- Renewal Agreement with Regus dated April 9, 2018 (Filed With SEC on December 14, 2018)
- Amended and Restated Stockholders Agreement dated October 25, 2017 (Filed With SEC on December 14, 2018)
- Sublicense Agreement with Chelexa Biosciences, Inc. dated May 26, 2017 (Filed With SEC on December 14, 2018)
- Amendment No. 2 to Sublicense Agreement with Chelexa Biosciences, Inc. dated August 29, 2018 (Filed With SEC on October 10, 2018)
- Amendment No. 1 to Sublicense Agreement with Chelexa Biosciences, Inc. dated August 22, 2018 (Filed With SEC on October 10, 2018)
